-
1.
公开(公告)号:AU2005286592A1
公开(公告)日:2006-03-30
申请号:AU2005286592
申请日:2005-09-23
Applicant: REDDY US THERAPEUTICS INC , PAL MANOJIT , KALLEDA SRINIVAS , PADAKANTI SRINIVAS , SWAMY NALIVELA KUMAR , KOTESWAR YELESWARAPU , CHRISTOPHER ALEXANDER , ISH KHANNA , IQBAL JAVED , PILLARISETTI SIVARAM , BARANGE DEEPAK
Inventor: BARANGE DEEPAK , ALEXANDER CHRISTOPHER W , KALLEDA SRINIVAS , PAL MANOJIT , SWAMY NALIVELA KUMAR , YELESWARAPU KOTESWAR RAO , PADAKANTI SRINIVAS , PILLARISETTI SIVARAM , IQBAL JAVED , KHANNA ISH KUMAR
IPC: A61K31/506 , C07D239/46 , C07D403/04
-
2.NOVEL PYRIMIDINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM 审中-公开
Title translation: 新嘧啶化合物,PROCESS FOR THEIR和含有组合物公开(公告)号:EP1796673A2
公开(公告)日:2007-06-20
申请号:EP05799686.0
申请日:2005-09-23
Applicant: Reddy US Therapeutics, Inc. , Kalleda, Srinivas , Padakanti, Srinivas , Swamy, Nalivela, Kumara , Rao, Yeleswarapu Koteswar , Alexander, Christopher W. , Khanna, Ish Kumar , Iqbal, Javed , Pillarisetti, Sivaram , Pal, Manojit , Barange, Deepak
Inventor: PAL, Manojit , KALLEDA, Srinivas , PADAKANTI, Srivinas , KUMAR SWAMY, Nalivela, Plor 191, J.P.N. , YELESWARAPU, Koteswar, Rao,Flat 202,Krishna Arcade , ALEXANDER, Christopher, W. , KHANNA, Ish, Kumar , IQBAL, Javed, Flat 101, Sri Krishna Residency , PILLARISETTI, Sivaram , BARANGE, Deepak, H.No.235, c/o A. Srinivas
IPC: A61K31/506 , C07D403/04 , C07D239/46
CPC classification number: C07D405/14 , C07D239/30 , C07D239/40 , C07D239/42 , C07D239/46 , C07D239/47 , C07D239/48 , C07D239/50 , C07D239/54 , C07D401/04 , C07D403/12 , C07D405/12
Abstract: The present invention provides new heterocyclic compounds, particularly substituted pyrimidines, methods and compositions for making and using these heterocyclic compounds, and methods for treating a variety of diseases and disease states, including atherosclerosis, arthritis, restenosis, diabetic nephropathy, or dyslipidemia, or disease states mediated by the low expression of Perlecan.
-
3.NOVEL PYRIMIDINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM 审中-公开
Title translation: 新型吡咯烷酮化合物,其制备方法及其组合物公开(公告)号:WO2006034473A3
公开(公告)日:2006-12-14
申请号:PCT/US2005034243
申请日:2005-09-23
Applicant: REDDY US THERAPEUTICS INC , PAL MANOJIT , KALLEDA SRINIVAS , PADAKANTI SRINIVAS , KUMAR SWAMY NALIVELA , YELESWARAPU KOTESWAR RAO , ALEXANDER CHRISTOPHER W , KHANNA ISH KUMAR , IQBAL JAVED , PILLARISETTI SIVARAM , BARANGE DEEPAK
Inventor: PAL MANOJIT , KALLEDA SRINIVAS , PADAKANTI SRINIVAS , KUMAR SWAMY NALIVELA , YELESWARAPU KOTESWAR RAO , ALEXANDER CHRISTOPHER W , KHANNA ISH KUMAR , IQBAL JAVED , PILLARISETTI SIVARAM , BARANGE DEEPAK
IPC: A61K31/506 , C07D239/46 , C07D403/04
CPC classification number: C07D405/14 , C07D239/30 , C07D239/40 , C07D239/42 , C07D239/46 , C07D239/47 , C07D239/48 , C07D239/50 , C07D239/54 , C07D401/04 , C07D403/12 , C07D405/12
Abstract: The present invention provides new heterocyclic compounds, particularly substituted pyrimidines, methods and compositions for making and using these heterocyclic compounds, and methods for treating a variety of diseases and disease states, including atherosclerosis, arthritis, restenosis, diabetic nephropathy, or dyslipidemia, or disease states mediated by the low expression of Perlecan.
Abstract translation: 本发明提供新的杂环化合物,特别是取代的嘧啶,用于制备和使用这些杂环化合物的方法和组合物,以及用于治疗各种疾病和疾病状态的方法,包括动脉粥样硬化,关节炎,再狭窄,糖尿病性肾病或血脂异常或疾病 由Perlecan低表达介导的状态。
-
4.NOVEL PYRIDINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM 审中-公开
Title translation: 新型吡啶化合物及其制备方法及其组合物公开(公告)号:WO2006034474A2
公开(公告)日:2006-03-30
申请号:PCT/US2005/034244
申请日:2005-09-23
Applicant: REDDY US THERAPEUTICS, INC. , KALLEDA, Srinivas , PADAKANTI, Srinivas , KUMARSAMY, Nalivela , ALEXANDER, Christopher W. , KHANNA, Ish , IQBAL, Javed , PILLARISETTI, Ram , MAITRA, Santanu , ROBERTS, Gayla, R. , SAGI, Lavanya
Inventor: KALLEDA, Srinivas , PADAKANTI, Srinivas , KUMARSAMY, Nalivela , ALEXANDER, Christopher W. , KHANNA, Ish , IQBAL, Javed , PILLARISETTI, Ram , MAITRA, Santanu , ROBERTS, Gayla, R. , SAGI, Lavanya , YELESWARAPU, Koteswar Rao
IPC: A61K31/541 , A61K31/5377 , A61K31/496 , A61K31/4545 , A61K31/4439 , A61K31/44 , C07D417/02 , C07D403/02 , C07D413/02 , C07D401/02
CPC classification number: C07D405/14 , C07D239/30 , C07D239/40 , C07D239/42 , C07D239/46 , C07D239/47 , C07D239/48 , C07D239/50 , C07D239/54 , C07D401/04 , C07D403/12 , C07D405/12
Abstract: The present invention provides new heterocyclic compounds, particularly substituted pyridines, methods and compositions for making and using these heterocyclic compounds, and methods for treating a variety of diseases and disease states, including atherosclerosis, arthritis, restenosis, diabetic nephropathy, or dyslipidemia, or disease states mediated by the low expression of Perlecan.
Abstract translation: 本发明提供新的杂环化合物,特别是取代的吡啶,制备和使用这些杂环化合物的方法和组合物,以及用于治疗各种疾病和疾病状态的方法,包括动脉粥样硬化,关节炎,再狭窄,糖尿病性肾病或血脂异常或疾病 由Perlecan低表达介导的状态。
-
5.NOVEL PYRIMIDINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM 审中-公开
Title translation: 新的嘧啶化合物,它们的制备方法和含有它们的组合物公开(公告)号:WO2006034473A2
公开(公告)日:2006-03-30
申请号:PCT/US2005/034243
申请日:2005-09-23
Applicant: REDDY US THERAPEUTICS, INC. , KALLEDA, Srinivas , PADAKANTI, Srinivas , KUMAR SWAMY, Nalivela , YELESWARAPU, Koteswar, Rao , ALEXANDER, Christopher, W. , KHANNA, Ish, Kumar , IQBAL, Javed , PILLARISETTI, Sivaram , PAL, Manojit , BARANGE, Deepak
Inventor: KALLEDA, Srinivas , PADAKANTI, Srinivas , KUMAR SWAMY, Nalivela , YELESWARAPU, Koteswar, Rao , ALEXANDER, Christopher, W. , KHANNA, Ish, Kumar , IQBAL, Javed , PILLARISETTI, Sivaram , PAL, Manojit , BARANGE, Deepak
IPC: A61K31/541 , A61K31/5377 , A61K31/496 , A61K31/4545 , A61K31/4439 , A61K31/44 , C07D417/02 , C07D403/02 , C07D413/02 , C07D401/02
CPC classification number: C07D405/14 , C07D239/30 , C07D239/40 , C07D239/42 , C07D239/46 , C07D239/47 , C07D239/48 , C07D239/50 , C07D239/54 , C07D401/04 , C07D403/12 , C07D405/12
Abstract: The present invention provides new heterocyclic compounds, particularly substituted pyrimidines, methods and compositions for making and using these heterocyclic compounds, and methods for treating a variety of diseases and disease states, including atherosclerosis, arthritis, restenosis, diabetic nephropathy, or dyslipidemia, or disease states mediated by the low expression of Perlecan.
Abstract translation: 本发明提供了新的杂环化合物,特别是取代的嘧啶,制备和使用这些杂环化合物的方法和组合物,以及治疗多种疾病和疾病状态的方法,包括动脉粥样硬化,关节炎,再狭窄, 糖尿病性肾病或血脂异常,或由基底膜蛋白低表达介导的疾病状态。 p>
-
-
-
-